DXR

Daxor Corporation

Price

$8.69

return (12m)

-33.61%

p/e

5.54

p/bv

0.86

DIVIDEND YIELD

0.00%

DXR price

Daxor Corporation

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*The amount considers the reinvestment of dividends.

Return on Investment DXR

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-19.57%

3 months

-17.08%

1 year

-33.61%

2 years

-4.85%

5 years

-21.89%

10 years

11.27%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals DXR

Valuation

P/E

5.54

Sector 8.02

Industry 8.02

P/BV

0.86

Sector 1.65

Industry 1.65

P/Revenue (PSR)

51.20

Sector 1.66

Industry 1.66

EV/EBITDA

Sector -193,371.46

Industry -193,371.46

EV/EBIT

Sector -38,355,244.89

Industry -38,355,244.89

P/EBITDA

4.65

Sector 1.36

Industry 1.36

P/EBIT

20.16

Sector 0.07

Industry 0.07

P/Total Assets

0.86

Sector 0.77

Industry 0.77

P/Net Current Assets

7.71

Sector -1.83

Industry -1.83

P/Working Capital

Sector -5.70

Industry -5.70

EPS

1.61

Sector 0.73

Industry 0.73

BVPS

10.40

Sector 10.02

Industry 10.02

Efficiency

Gross Margin

54.58%

Sector 36.34%

Industry 36.34%

EBITDA Margin

-14,382.88%

Sector 6.85%

Industry 6.85%

EBIT Margin

100.00%

Sector 4.48%

Industry 4.48%

Net Profit Margins

100.00%

Sector 2.56%

Industry 2.56%

Asset Turnover

0.00

Sector 0.11

Industry 0.11

Profitability

ROE

15.48%

Sector 3.07%

Industry 3.07%

ROA

15.48%

Sector -0.43%

Industry -0.43%

ROIC

15.48%

Sector -1.83%

Industry -1.83%

Dividends

Dividend yield

0.00%

Sector 0.52%

Industry 0.52%

Payout

0.00%

Sector 10.22%

Industry 10.22%

Debt

Current Ratio

Sector 1.45

Industry 1.45

Net Debt / EBITDA

Sector -7.06

Industry -7.06

Net Debt / EBIT

Sector -55,132,930.11

Industry -55,132,930.11

Net Debt / Equity

Sector -0.84

Industry -0.84

Gross Debt / Equity

Sector -0.57

Industry -0.57

Equity/Assets

1.00

Sector 0.43

Industry 0.43

Liabilities/Assets

0.00

Sector 0.53

Industry 0.53

Growth

5Y Revenue CAGR

25.58%

Sector -

Industry -

5Y Earnings CAGR

11.07%

Sector -

Industry -

Fundamentals DXR

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Daxor Corporation ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$8.69

Fair Value

$19.41

Upside

123.36%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

DXR - Historical Dividends

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	01/04/2018	01/12/2018	0.03000000
Dividends	12/20/2016	12/29/2016	0.03000000
Dividends	12/18/2015	12/29/2015	0.04000000
Dividends	12/04/2014	12/26/2014	0.03000000
Dividends	12/05/2013	12/27/2013	0.05000000
Dividends	12/07/2012	12/27/2012	0.10000000
Dividends	08/10/2012	08/24/2012	0.10000000
Dividends	11/16/2011	11/30/2011	0.10000000
Dividends	05/30/2011	06/16/2011	0.15000000
Dividends	12/14/2010	12/30/2010	0.65000000
Dividends	09/13/2010	09/30/2010	0.25000000
Dividends	05/28/2010	06/16/2010	0.10000000
Dividends	12/08/2009	12/24/2009	1.00000000
Dividends	08/21/2009	09/08/2009	0.25000000
Dividends	05/27/2009	06/15/2009	0.10000000
Dividends	12/10/2008	12/30/2008	1.00000000
Dividends	10/31/2008	11/26/2008	0.25000000
Dividends	07/24/2008	08/27/2008	0.25000000
Dividends	04/28/1997	05/30/1997	0.50000000

ABOUT Daxor Corporation

Daxor Corporation

Average Investor10 user rating

4.0 (1 people)

United States

- year

Founded:

1992

Time since IPO - 34 years

-

Employees

Daxor Corporation (United States) is listed on the Nasdaq and has a market capitalization of $44.47 million, with shareholders equity totaling $51.83 million.

The Company is listed on the [MARKET_NAME]

Over the past 12 months, Daxor Corporation reported $868.52 Thousand in revenue, generating net income of $8.03 million.

Key financial metrics include a P/E ratio of 5.54, a price-to-book (P/B) ratio of 0.86, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker DXR.

Market cap

$44.47 million

Net worth

$51.83 million

$51,832,130.00

Assets

$51.86 million

$51,855,727.00

Total Shares Outstanding

4.99 million

4,985,000

Average Daily Trading Volume

$5.38 Thousand

$5,380.00

Sector

Others

Industry

Others

DXR

DXR revenue and profits

Financial Results DXR

DRAG THE FRAME TO SEE MORE DATA

DXR cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

UNH - UnitedHealth Group Incorporated

$402.48 23,79% (12M)

P/E

22.30

2.23%

ROE

16.47%

P/BV

3.52

STLA - Stellantis NV

$4.62 --54,84% (12M)

P/E

-0.52

0.00%

ROE

-35.93%

P/BV

0.19

SHEL - Shell PLC ADR

$104.22 46,37% (12M)

P/E

7.41

2.79%

ROE

22.05%

P/BV

1.54

COR - Cencora Inc.

$341.48 0,92% (12M)

P/E

24.58

0.72%

ROE

96.34%

P/BV

19.92

TTE - TotalEnergies SE ADR

$92.47 61,41% (12M)

P/E

6.57

4.27%

ROE

25.94%

P/BV

1.59

ALIZY - Allianz SE ADR

$49.22 --10,64% (12M)

P/E

13.51

2.77%

ROE

18.73%

P/BV

2.42

NSRGY - Nestle SA ADR

$102.93 11,45% (12M)

P/E

12.10

3.90%

ROE

60.60%

P/BV

7.33

ELV - Elevance Health Inc

$415.05 35,67% (12M)

P/E

17.74

1.65%

ROE

11.52%

P/BV

2.03